
    
      The study is a prospective, observational study utilizing peripheral blood assays that will
      be collected at time points that are considered standard of care at most institutions. 100
      participants will be enrolled in study. Participants will have peripheral blood collected at
      4 months and 12 months after liver transplant, as well as any for cause time points.
      Participants will also have liver biopsies collected at these time points. The results from
      the liver biopsies will be used in correlation with the results from the peripheral blood
      assays.
    
  